Summit Securities Group’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-127
Closed -$1.01K 1229
2025
Q1
$1.01K Buy
+127
New +$1.01K ﹤0.01% 565
2020
Q1
Hold
0
241
2019
Q4
Sell
-5,800
Closed -$814K 279
2019
Q3
$814K Buy
+5,800
New +$814K 0.07% 55